Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001401914-22-000007
Filing Date
2022-01-28
Accepted
2022-01-28 16:02:24
Documents
1
Period of Report
2022-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164340372783895.html 4  
1 FORM 4 wf-form4_164340372783895.xml 4 3944
  Complete submission text file 0001401914-22-000007.txt   5553
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DARE BIOSCIENCE, INC. 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address
Walters-Hoffert Lisa (Reporting) CIK: 0001711576 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 22568723